Zurich Cantonal Bank’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.13M | Sell |
39,984
-7,660
| -16% | -$522K | 0.01% | 901 |
|
|
2026
Q1 | $3.08M | Buy |
47,644
+12,139
| +34% | +$856K | 0.01% | 821 |
|
|
2025
Q4 | $2.39M | Sell |
35,505
-2,227
| -6% | -$150K | 0.01% | 880 |
|
|
2025
Q3 | $2.77M | Buy |
37,732
+1,651
| +5% | +$110K | 0.01% | 786 |
|
|
2025
Q2 | $1.88M | Buy |
36,081
+4,013
| +13% | +$228K | ﹤0.01% | 895 |
|
|
2025
Q1 | $2.05M | Sell |
32,068
-804
| -2% | -$46.7K | 0.01% | 811 |
|
|
2024
Q4 | $1.57M | Buy |
32,872
+2,241
| +7% | +$115K | ﹤0.01% | 967 |
|
|
2024
Q3 | $1.75M | Buy |
30,631
+1,586
| +5% | +$90.9K | 0.01% | 845 |
|
|
2024
Q2 | $1.52M | Buy |
29,045
+2,740
| +10% | +$120K | ﹤0.01% | 851 |
|
|
2024
Q1 | $1.07M | Sell |
26,305
-1,066
| -4% | -$40K | ﹤0.01% | 1033 |
|
|
2023
Q4 | $1.01M | Buy |
27,371
+504
| +2% | +$19K | ﹤0.01% | 1061 |
|
|
2023
Q3 | $1.03M | Buy |
26,867
+3,560
| +15% | +$146K | ﹤0.01% | 953 |
|
|
2023
Q2 | $841K | Buy |
23,307
+2,404
| +12% | +$82K | ﹤0.01% | 1027 |
|
|
2023
Q1 | $798K | Buy |
20,903
+697
| +3% | +$32.7K | ﹤0.01% | 1012 |
|
|
2022
Q4 | $1.15M | Buy |
20,206
+1,625
| +9% | +$83.2K | 0.01% | 821 |
|
|
2022
Q3 | $735K | Buy |
18,581
+1,847
| +11% | +$81.6K | ﹤0.01% | 969 |
|
|
2022
Q2 | $736K | Sell |
16,734
-2,085
| -11% | -$90.2K | ﹤0.01% | 991 |
|
|
2022
Q1 | $751K | Sell |
18,819
-525
| -3% | -$18.7K | ﹤0.01% | 1075 |
|
|
2021
Q4 | $778K | Buy |
19,344
+4,951
| +34% | +$185K | ﹤0.01% | 1148 |
|
|
2021
Q3 | $586K | Buy |
14,393
+25
| +0.2% | +$1.04K | ﹤0.01% | 1202 |
|
|
2021
Q2 | $652K | Buy |
14,368
+123
| +0.9% | +$5.44K | ﹤0.01% | 1069 |
|
|
2021
Q1 | $594K | Sell |
14,245
-2,667
| -16% | -$122K | ﹤0.01% | 1115 |
|
|
2020
Q4 | $722K | Buy |
16,912
+968
| +6% | +$34.8K | ﹤0.01% | 1091 |
|
|
2020
Q3 | $419K | Hold |
15,944
| – | – | ﹤0.01% | 1168 |
|
|
2020
Q2 | $427K | Buy |
15,944
+4,797
| +43% | +$108K | ﹤0.01% | 1090 |
|
|
2020
Q1 | $201K | Buy |
11,147
+1,111
| +11% | +$21.1K | ﹤0.01% | 1233 |
|
|
2019
Q4 | $178K | Buy |
10,036
+1,911
| +24% | +$33.1K | ﹤0.01% | 1407 |
|
|
2019
Q3 | $126K | Hold |
8,125
| – | – | ﹤0.01% | 1488 |
|
|
2019
Q2 | $140K | Hold |
8,125
| – | – | ﹤0.01% | 1433 |
|
|
2019
Q1 | $131K | Sell |
8,125
-1,666
| -17% | -$27K | ﹤0.01% | 1417 |
|
|
2018
Q4 | $143K | Buy |
9,791
+2,430
| +33% | +$38.8K | ﹤0.01% | 1389 |
|
|
2018
Q3 | $134K | Hold |
7,361
| – | – | ﹤0.01% | 1542 |
|
|
2018
Q2 | $124K | Hold |
7,361
| – | – | ﹤0.01% | 1538 |
|
|
2018
Q1 | $144K | Hold |
7,361
| – | – | ﹤0.01% | 1396 |
|
|
2017
Q4 | $149K | Buy |
7,361
+2,256
| +44% | +$41.5K | ﹤0.01% | 1355 |
|
|
2017
Q3 | $89K | Hold |
5,105
| – | – | ﹤0.01% | 1463 |
|
|
2017
Q2 | $65K | Buy |
5,105
+696
| +16% | +$9.3K | ﹤0.01% | 1601 |
|
|
2017
Q1 | $57K | Hold |
4,409
| – | – | ﹤0.01% | 1667 |
|
|
2016
Q4 | $44K | Hold |
4,409
| – | – | ﹤0.01% | 1774 |
|
|
2016
Q3 | $53K | Buy |
4,409
+593
| +16% | +$6.06K | ﹤0.01% | 1598 |
|
|
2016
Q2 | $33K | Hold |
3,816
| – | – | ﹤0.01% | 1740 |
|
|
2016
Q1 | $36K | Hold |
3,816
| – | – | ﹤0.01% | 1599 |
|
|
2015
Q4 | $66K | Buy |
3,816
+2,713
| +246% | +$43.2K | ﹤0.01% | 1302 |
|
|
2015
Q3 | $15K | Buy |
1,103
+639
| +138% | +$12.8K | ﹤0.01% | 1633 |
|
|
2015
Q2 | $10K | Hold |
464
| – | – | ﹤0.01% | 1379 |
|
|
2015
Q1 | $7K | Buy |
+464
| New | +$6.69K | ﹤0.01% | 1605 |
|
|
2014
Q3 | – | Sell |
-60,000
| Closed | -$593K | – | 976 |
|
|
2014
Q2 | $593K | Buy |
60,000
+20,000
| +50% | +$170K | 0.02% | 683 |
|
|
2014
Q1 | $508K | Hold |
40,000
| – | – | 0.02% | 693 |
|
|
2013
Q4 | $600K | Hold |
40,000
| – | – | 0.02% | 590 |
|
|
2013
Q3 | $442K | Sell |
40,000
-50,000
| -56% | -$417K | 0.02% | 636 |
|
|
2013
Q2 | $715K | Buy |
+90,000
| New | +$573K | 0.03% | 500 |
|
Other funds holding HALO
Zurich Cantonal Bank's HALO Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Halozyme (HALO) stake by 16% in Q2 2026, selling an estimated $522K and leaving 39,984 shares worth $3.13M. The position accounts for 0.01% of the portfolio, ranked #901.
Zurich Cantonal Bank first reported a position in HALO in Q2 2013 and has held it in 51 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Zurich Cantonal Bank held 39,984 shares of Halozyme worth $3.13M as of Q2 2026.
- Zurich Cantonal Bank sold 7,660 Halozyme shares in Q2 2026, an estimated $522K.
- Halozyme made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #901 holding.
- Zurich Cantonal Bank first reported a position in Halozyme in Q2 2013 and has held it in 51 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.